Sustainable Markets Initiative Health Systems Taskforce

At the invitation of His Royal Highness the Prince of Wales, Pascal Soriot has convened 13 leaders from across the healthcare system to form a Health Systems Taskforce as part of the Sustainable Markets Initiative (SMI). Collectively, the group aims to accelerate the delivery of net zero, sustainable healthcare to improve individual, societal and planetary health.
 

Formally launched at COP26, the SMI Health Systems Taskforce is championed by our Chief Executive Officer, Pascal Soriot, and brings together CEOs or equivalents from global life sciences, healthcare systems,  multilateral and policy institutions and academia.

Recognising that the healthcare sector must do more to drive progress towards a sustainable future, Taskforce members AstraZeneca, GSK, Merck, Roche, Samsung Biologics, Sanofi, Novo Nordisk, the World Health Organization, UNICEF, NHS England, the Sustainable Healthcare Coalition, the Health and the Karolinska Institutet and the University of Pavia, have committed to developing a collective roadmap to a sustainable health system.



Accelerating the delivery of net zero health systems



With around 4% of greenhouse gases coming from the healthcare sector, it’s imperative that we take action and make healthcare more sustainable – for the health of people, society and the planet.The SMI Health Systems Taskforce has a key role to play, and I am honoured and excited to be working with other like-minded leaders to drive change. Together, we can harness the power of innovation and shape and advance policies that will accelerate the delivery of net zero healthcare.

Pascal Soriot Chief Executive Officer, AstraZeneca

In coordination with other SMI Taskforces, the Health Systems Taskforce will focus its attention on delivering action in the following three priority areas:


1. Digital healthcare

The aim is to leverage digital innovation and technology to drive the transition to net zero across health systems, with an initial focus on decarbonising clinical trials.


2. Supply chains

The Taskforce aims to accelerate the net zero transition across health systems supply chains, recognising that approximately 50% of healthcare emissions come from the product supply chain.

3. Patient care pathways

Keeping patients at the centre, it is critical to focus on identifying opportunities to deliver net zero patient care while improving health and societal outcomes.


The Taskforce will also focus on the development of initiatives and shared commitments in the areas of:

  • The measurement of and metrics for the assessment of the environmental impact of health systems; and

  • Education and wider policy change



tags

  • Sustainability